View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 22, 2020

Pipeline drug companies must scope the long-term competition to win seed funding, says Pfizer

By Victoria Smith

According to Barbara Dalton, Pfizer Ventures senior managing partner, in order to win Pfizer Ventures’ funding, drug development start-ups must have carried out their due diligence via long-term competitors, instead of predicting competition based on present environment.

In March, Pfizer announced the joint development of a potential Covid-19 messenger ribonucleic acid (mRNA) vaccine with BioNTech. More information on drugs and vaccines in development for Covid-19 can be found in GlobalData’s Drugs database.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU